Evidence map›Paper›PMID 25730388›Full record

ReviewMolecules (Basel, Switzerland)2015

Lectins with potential for anti-cancer therapy.

Tammy Yau, Xiuli Dan, Charlene Cheuk Wing Ng, Tzi Bun Ng

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 223 citations in OpenAlex.

  1. Article
  2. Protein Fraction and Derived Peptides fromInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Lectin fromACS omega · 2025
    Article
  7. Article
  8. Article
  9. Recombinant Microneme Proteins MIC1 and MIC4 fromPathogens (Basel, Switzerland) · 2025
    Article
  10. Tepary Bean (International journal of molecular sciences · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Directed Mutagenesis for Arginine Substitution of aInternational journal of molecular sciences · 2024
    Article
  15. Review
  16. Article
  17. Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Review
  20. EGFR and p38Pharmaceuticals (Basel, Switzerland) · 2023
    Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Tammy YauDepartment of Neurobiology, Physiology, and Behavior, University of California, Davis, CA 95616, USA. tkyau@ucdavis.edu.
Xiuli DanSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China. danxiuli@hotmail.com.
Charlene Cheuk Wing NgSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China. charlene.cw.ng@gmail.com.
Tzi Bun NgSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China. b021770@mailserv.cuhk.edu.hk.
Chinese University of Hong Kong · CNUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article reviews lectins of animal and plant origin that induce apoptosis and autophagy of cancer cells and hence possess the potential of being developed into anticancer drugs. Apoptosis-inducing lectins encompass galectins, C-type lectins, annexins, Haliotis discus discus lectin, Polygonatum odoratum lectin, mistletoe lectin, and concanavalin A, fucose-binding Dicentrarchus labrax lectin, and Strongylocentrotus purpuratus lectin, Polygonatum odoratum lectin, and mistletoe lectin, Polygonatum odoratum lectin, autophagy inducing lectins include annexins and Polygonatum odoratum lectin.

Indexed as

AnimalsAntineoplastic AgentsApoptosisAutophagyHumansLectinsNeoplasmsAntineoplastic AgentsLectins

Identifiers

PMID25730388
PMCPMC6272365
OpenAlexW2095217483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.